KILITCH DRUGS (INDIA)
Back to Income Statement
|
KILITCH DRUGS (INDIA) Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹198 Cr | ₹154 Cr | ₹140 Cr | ₹114 Cr | ₹69 Cr |
What is the latest Revenue of KILITCH DRUGS (INDIA) ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹198 Cr |
| Mar2024 | ₹154 Cr |
| Mar2023 | ₹140 Cr |
| Mar2022 | ₹114 Cr |
| Mar2021 | ₹69 Cr |
How is Revenue of KILITCH DRUGS (INDIA) Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹198 Cr | 28.47 | |
| Mar2024 | ₹154 Cr | 10.58 | |
| Mar2023 | ₹140 Cr | 22.20 | |
| Mar2022 | ₹114 Cr | 66.71 | |
| Mar2021 | ₹69 Cr | - | |
Compare Revenue of peers of KILITCH DRUGS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KILITCH DRUGS (INDIA) | ₹601.7 Cr | 1.5% | 0.6% | 1.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹408,019.0 Cr | -3.5% | -5.4% | -3.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,752.0 Cr | -3.6% | 0.2% | 11.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,542.0 Cr | -0.5% | 5.9% | 20.3% | Stock Analytics | |
| CIPLA | ₹115,883.0 Cr | -1.8% | -4.8% | -1.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,024.7 Cr | -1.7% | -7.3% | -12.1% | Stock Analytics | |
KILITCH DRUGS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KILITCH DRUGS (INDIA) | 1.5% |
0.6% |
1.3% |
| SENSEX | -1.9% |
-2.2% |
7.4% |
You may also like the below Video Courses